Anti-adhesion Formula for Urinary Tract Infections (Science-Based)
Although normally a commensal inhabitant of the human intestinal and gastrointestinal tract, Escherichia coli is the most common urinary tract pathogen, with overgrowth and colonization accounting for 85% of urinary tract infections.
Cranberry extracts and ᴅ-mannose each independently inhibit one of the two adhesion methods used by E. coli.
Combined in a synergistic and novel formula, D-Mannose SAP targets both type 1 (FimH) and fimbrial-mediated type P adhesion of E. coli. coli to the urinary tract mucosa.
D-Mannose SAP is specifically intended for the treatment and prevention of E. coli urinary tract infections.
Cranberry extracts and ᴅ-mannose each independently inhibit one of the two adhesion methods used by E. coli.
Combined in a synergistic and novel formula, D-Mannose SAP targets both type 1 (FimH) and fimbrial-mediated type P adhesion of E. coli. coli to the urinary tract mucosa.
D-Mannose SAP is specifically intended for the treatment and prevention of E. coli urinary tract infections.
Adults: Take 5 g (approximately 2.5 tsp) once or twice daily or as directed by your healthcare practitioner.
Medicinal ingredients (per 5 g (approximately 2 1/2 teaspoons)): Cranberry (Vaccinium macrocarpon) 400 mg - Mannose 4600 mg Non-medicinal ingredients: None
